Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
OncoSil Medical Ltd ( (AU:OSL) ) has shared an announcement.
OncoSil Medical has opened its entitlement offer to eligible shareholders, confirming that the prospectus and personalised entitlement and acceptance forms have been dispatched and that applications will be accepted until 5:00 p.m. AEDT on 10 March 2026. The timetable outlines expected dates for the close of the offer, an extraordinary general meeting on 12 March, and the subsequent allotment and trading of new shares and options, which are subject to shareholder approval for various placement-related securities.
The company will send a notice of extraordinary general meeting to shareholders, seeking approval for elements of the capital raising structure including director participation, tranche two placement shares and lead manager options. The capital raising via the entitlement offer and associated placement is a key step in strengthening OncoSil Medical’s balance sheet, potentially supporting its commercial expansion in pancreatic cancer treatment markets where its device is already approved and in use.
The most recent analyst rating on (AU:OSL) stock is a Hold with a A$0.69 price target. To see the full list of analyst forecasts on OncoSil Medical Ltd stock, see the AU:OSL Stock Forecast page.
More about OncoSil Medical Ltd
OncoSil Medical is a global medical device company focused on interventional oncology, developing targeted intratumoural radiation therapies to improve outcomes for cancer patients. Its lead product, the OncoSil device for unresectable locally advanced pancreatic cancer, delivers phosphorus-32 microparticles directly into tumours and holds CE Mark approval and breakthrough device designation in Europe and the U.S., with commercial availability in more than 30 countries.
Average Trading Volume: 37,719
Technical Sentiment Signal: Sell
Current Market Cap: A$14.85M
For detailed information about OSL stock, go to TipRanks’ Stock Analysis page.